CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Arshman Sahid

OPENALEX: A5094047584↗

Affiliations

Organizations

Sydney Local Health Districtauthorship · AU The University of Sydneyauthorship · AU

Public evidence

1 connected articles

A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol.2024 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Arshman Sahid - Medical Cannabis Research Engine